← Mechanisms of action
CD40
SINGLE PROTEINHomo sapiens
Preferred name: Tumor necrosis factor receptor superfamily member 5 ChEMBL ↗
Linked proteins
Drugs acting on this target (39)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| mil97 | Adcc | experimental | mAb | CD40 |
| cd40 ligand | Agonist | experimental | Recombinant protein | Tumor necrosis factor receptor superfamily member 5 agonist |
| cdx-1140 | Agonist | experimental | Peptide | Tumor necrosis factor receptor superfamily member 5 agonist |
| cp-870893 | Agonist | experimental | mAb | CD40 agonist |
| inezetamab | Agonist | experimental | mAb | CD40 agonist |
| kk2269 | Agonist | experimental | mAb | CD40 agonist |
| lnf1901 | Agonist | experimental | mAb | CD40 agonist |
| m0324 | Agonist | experimental | mAb | CD40 agonist |
| tqb2916 | Agonist | experimental | mAb | CD40 |
| lucatumumab | Antagonist | experimental | mAb | CD40 antagonist |
| abbv-428 | Immunity, passive | experimental | mAb | CD40 immunity, passive |
| abbv-927 | Immunity, passive | experimental | mAb | CD40 immunity, passive |
| 2141 v-11 | Inhibitor | experimental | mAb | CD40 inhibitor |
| abbv-323 | Inhibitor | experimental | mAb | CD40 inhibitor |
| adc-1013 | Inhibitor | experimental | mAb | CD40 inhibitor |
| apx005m | Inhibitor | experimental | mAb | CD40 inhibitor |
| askp1240 | Inhibitor | experimental | mAb | CD40 inhibitor |
| bi 655064 | Inhibitor | experimental | mAb | CD40 inhibitor |
| biib063 | Inhibitor | experimental | mAb | CD40 inhibitor |
| bleselumab | Inhibitor | experimental | mAb | Tumor necrosis factor receptor superfamily member 5 inhibitor |
| cd40 ligand | Inhibitor | experimental | Recombinant protein | CD40 inhibitor |
| cdx-1140 | Inhibitor | experimental | Peptide | CD40 inhibitor |
| cfz533 | Inhibitor | experimental | mAb | CD40 inhibitor |
| chi lob 7/4 | Inhibitor | experimental | mAb | CD40 inhibitor |
| cp-870893 | Inhibitor | experimental | mAb | CD40 inhibitor |
| dacetuzumab | Inhibitor | experimental | mAb | CD40 inhibitor |
| ffp104 | Inhibitor | experimental | mAb | CD40 inhibitor |
| jnj-64457107 | Inhibitor | experimental | mAb | CD40 inhibitor |
| keliximab | Inhibitor | experimental | mAb | CD40 inhibitor |
| kpl-404 | Inhibitor | experimental | mAb | CD40 inhibitor |
| lucatumumab | Inhibitor | experimental | mAb | CD40 inhibitor |
| lvgn7409 | Inhibitor | experimental | mAb | CD40 inhibitor |
| opt101 | Inhibitor | experimental | Peptide | CD40 inhibitor |
| pg-102 | Inhibitor | experimental | mAb | CD40 inhibitor |
| sea-cd40 | Inhibitor | experimental | mAb | CD40 inhibitor |
| selicrelumab | Inhibitor | experimental | mAb | CD40 inhibitor |
| tnx-100 | Inhibitor | experimental | mAb | CD40 inhibitor |
| yh003 | Inhibitor | experimental | mAb | CD40 inhibitor |
| infliximab (remicade) | Partial agonist | approved | mAb | CD40 partial agonist |